Bülent Eser

2.5k total citations
119 papers, 1.9k citations indexed

About

Bülent Eser is a scholar working on Hematology, Oncology and Epidemiology. According to data from OpenAlex, Bülent Eser has authored 119 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Hematology, 27 papers in Oncology and 26 papers in Epidemiology. Recurrent topics in Bülent Eser's work include Hematopoietic Stem Cell Transplantation (17 papers), Multiple Myeloma Research and Treatments (12 papers) and Hemoglobinopathies and Related Disorders (11 papers). Bülent Eser is often cited by papers focused on Hematopoietic Stem Cell Transplantation (17 papers), Multiple Myeloma Research and Treatments (12 papers) and Hemoglobinopathies and Related Disorders (11 papers). Bülent Eser collaborates with scholars based in Türkiye, Cyprus and United States. Bülent Eser's co-authors include Ali Ünal, Mustafa Çetın, Leylagül Kaynar, Fevzi Altuntaş, Özlem Er, Mustafa Altınbaş, Metin Özkan, İ̇smail Sarı, H.Ş. Çoşkun and Serdar Soyuer and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Bülent Eser

117 papers receiving 1.8k citations

Peers

Countries citing papers authored by Bülent Eser

Since Specialization

Citations

This map shows the geographic impact of Bülent Eser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bülent Eser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bülent Eser more than expected).

Fields of papers citing papers by Bülent Eser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bülent Eser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bülent Eser. The network helps show where Bülent Eser may publish in the future.

Co-authorship network of co-authors of Bülent Eser

This figure shows the co-authorship network connecting the top 25 collaborators of Bülent Eser. A scholar is included among the top collaborators of Bülent Eser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bülent Eser. Bülent Eser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-world data on the effectiveness and safety of Ixazomib-Lenalidomide-Dexamethasone therapy in relapsed/refractory multiple myeloma patients: a multicenter experience in Turkey 2023 ·Journal of Chemotherapy ·(unknown), Mehmet Sinan Dal, Tuğçe Nur Yiğenoğlu, (unknown), (unknown), Semih Başçı, (unknown), Serdal Korkmaz, (unknown), Murat Albayrak, Abdulkadir Baştürk, Düzgün Özatlı, Mehmet Hilmi Doğu, Tuba Hacıbekiroğlu, Merih Kızıl Çakar, Turgay Ulaş, (unknown), (unknown), Bülent Eser, Fevzi Altuntaş	2
2	Flow cytometric analysis of platelet surface glycoproteins in the diagnosis of thirty-two Turkish patients with Glanzmann thrombasthenia: a multicenter experience 2021 ·TURKISH JOURNAL OF MEDICAL SCIENCES ·(unknown), Sabahattin Muhtaroğlu, Mustafa Yavuz Köker, Nazan Sarper, Emine Zengin, Canan Albayrak, Davut Albayrak, Bülent Zülfikar, (unknown), (unknown), Semih Yılmaz, Aysun Çetin, Bülent Eser, Mustafa Çetın	5
3	A Comparison of the BEAM and MITO/MEL Conditioning Regimens for Autologous Hematopoietic Stem Cell Transplantation in Hodgkin Lymphoma: An Analysis of Efficiency and Treatment-Related Toxicity 2020 ·Clinical Lymphoma Myeloma & Leukemia ·Mahmut Yeral, (unknown), (unknown), Can Boğa, Ali Ünal, Yener Koç, Leylagül Kaynar, (unknown), Bülent Eser, Hakan Özdoğu	4
4	Nodular lymphocyte predominant Hodgkin's lymphoma in daily practice: A multicenter experience 2017 ·Hematological Oncology ·(unknown), İsmet Aydoğdu, (unknown), Mehmet Şencan, (unknown), Ali Kaya, Mehmet Sinan Dal, (unknown), Mehmet Hilmi Doğu, Orhan Ayyıldız, Fahri Şahin, (unknown), Mehmet Birhan Yılmaz, (unknown), (unknown), Cengiz Demır, Ömür Gökmen Sevindik, Serdal Korkmaz, Bülent Eser, Fevzi Altuntaş	4
5	Evaluation of the efficacy and safety of original filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) in CD34+ peripheral hematopoietic stem cell mobilization procedures for allogeneic hematopoietic stem cell transplant donors 2016 ·Transfusion and Apheresis Science ·Serdar Şıvgın, (unknown), Muzaffer Keklık, Gökmen Zararsız, (unknown), Leylagül Kaynar, Bülent Eser, Mustafa Çetın, Ali Ünal	14
6	Coincidence of three solid tumors in a patient with multiple myeloma 2013 ·Chinese Medical Journal ·Muzaffer Keklık, Serdar Şıvgın, Kemal Denız, Halıt Karaca, Olgun Kontaş, (unknown), Celalettin Eroğlu, Ümmühan Abdülrezzak, (unknown), Leylagül Kaynar, Mustafa Çetın, Ali Ünal, Bülent Eser	2
7	The Impact of Pretransplant Hypoalbuminemia on Survival in patients With Leukemia Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): A Nutritional Problem? 2013 ·Transplantation Proceedings ·(unknown), Süleyman Baldane, (unknown), Muzaffer Keklık, Leylagül Kaynar, Fatih Kurnaz, (unknown), Gökmen Zararsız, (unknown), Ali Ünal, Bülent Eser	11
8	Encephalitozoon intestinalis: A Rare Cause of Diarrhea in an Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Recipient Complicated by Albendazole-Related Hepatotoxicity 2013 ·SHILAP Revista de lepidopterología ·Serdar Şıvgın, Bülent Eser, Leylagül Kaynar, Fatih Kurnaz, (unknown), Süleyman Yazar, Mustafa Çetın, Ali Ünal	5
9	Can bacteraemia lead to false positive results in 1,3-beta-d-glucan test? Analysis of 83 bacteraemia episodes in high-risk patients for invasive fungal infections 2011 ·Revista Iberoamericana de Micología ·Gökhan Metan, Ayşe Nedret Koç, (unknown), Leylagül Kaynar, Emine Alp, Bülent Eser	25
10	What should be the optimal cut-off of serum 1,3-β-d-glucan for the detection of invasive pulmonary aspergillosis in patients with haematological malignancies? 2011 ·Scandinavian Journal of Infectious Diseases ·Gökhan Metan, Ayşe Nedret Koç, (unknown), Leylagül Kaynar, Ahmet Öztürk, Emine Alp, Bülent Eser	19
11	Pretransplant serum ferritin level may be a predictive marker for outcomes in patients having undergone allogeneic hematopoietic stem cell transplantation 2011 ·Neoplasma ·(unknown), Süleyman Baldane, Leylagül Kaynar, Fatih Kurnaz, Çiğdem Pala, (unknown), (unknown), Ali Ünal, Bülent Eser	25
12	Acute renal failure after myeloablative allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and relationship with the quantity of transplanted cells 2010 ·Renal Failure ·Bülent Tokgöz, İsmail Koçyiğit, (unknown), Bülent Eser, Aydın Ünal, Leylagül Kaynar, Murat Hayri Sipahioğlu, Oktay Oymak, Cengiz Utaş, Mustafa Çetın	10
13	Are university students a favorable target group for blood donation campaigns? 2010 ·Turkish Journal of Hematology ·Bülent Eser, Fatih Kurnaz, Leylagül Kaynar, (unknown), Serdar Şıvgın, Ali Ünal, Mustafa Çetın	9
14	Therapeutic plasma exchange in patients with neurologic diseases: Retrospective multicenter study 2008 ·Transfusion and Apheresis Science ·Leylagül Kaynar, Fevzi Altuntaş, Ismet Aydogdu, Burhan Turgut, İsmail Koçyiğit, Sibel Hacıoğlu, Sevda İsmailoğulları, Nilda Turgut, Mehmet Ali Erkurt, İ̇smail Sarı, (unknown), (unknown), Bülent Eser, (unknown), Ali Ünal, Mustafa Çetın	48
15	The Role of Plasma Exchange in HELLP Syndrome 2005 ·Clinical and Applied Thrombosis/Hemostasis ·Bülent Eser, Muhammet Güven, Ali Ünal, Ramazan Coşkun, Fevzi Altuntaş, Murat Sungur, İbrahim Serdar Serin, İ̇smail Sarı, Mustafa Çetın	61
16	Meropenem +/− Granulocyte Colony Stimulating Factor in the Treatment of Febrile Neutropenic Patients with Cancer: Prospective Randomized Study 2004 ·Journal of Chemotherapy ·Özlem Er, H.Ş. Çoşkun, Mustafa Altınbaş, (unknown), Bülent Eser, (unknown), Fevzi Altuntaş, Ali Ünal	1
17	A randomized clinical trial of combination chemotherapy with and without low‐molecular‐weight heparin in small cell lung cancer 2004 ·Journal of Thrombosis and Haemostasis ·Mustafa Altınbaş, H.Ş. Çoşkun, Özlem Er, Metin Özkan, Bülent Eser, Ali Ünal, (unknown), Serdar Soyuer	367
18	Ifosfamide, Mesna, and Interferon-Alpha2A Combination Chemoimmunotherapy in Malignant Mesothelioma: Results of a Single Center in Central Anatolia 2004 ·Medical Oncology ·Mustafa Altınbaş, Özlem Er, Metin Özkan, Hasan Şenol Çoşkun, İnci Gülmez, Eyüp Ekici, Bünyamin Kaplan, Bülent Eser, Mustafa Özesmi	3
19	Evaluation of the Patients with Acute Intoxication 2002 ·DergiPark (Istanbul University) ·Muhammet Güven, Murat Sungur, Fatih Tanrıverdi, Bülent Eser, Zeynep Kekeç	12
20	Febril nötropenik bir hastada Listeria monocytogenes'e bağlı sepsis 2000 ·Orhan Yıldız, Bilgehan Aygen, Bülent Eser, (unknown), Bülent Sümerkan	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact